Cardiopulmonary Stress Testing Systems Market
Cardiopulmonary Stress Testing Systems Market Study by CPET Systems, Stress ECG, Pulse Oximeters, SPECT, and Stress Blood Pressure Monitors from 2023 to 2033
Analysis of Cardiopulmonary Stress Testing Systems Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Key Market Indicators 4.4. Market Dynamics 4.4.1. Drivers 4.4.1.1. Rising awareness among end-users about accurate assessment of cardiovascular diseases due to new monitoring technologies is significantly enhancing the diagnosis rate 4.4.1.2. Growing geriatric population propels adoption of preventive disease-monitoring products 4.4.2. Restraints 4.4.2.1. Shutdown of Chalk River resulting in shortage of Tc-99 m and reduction in the number of SPECT procedures 4.4.2.2. Implementation of legal provisions that promote cost containment/cost-cutting strategies 4.4.3. Opportunity 4.5. Global Market Analysis and Forecasts, 2023–2033 4.5.1. Market Revenue Projections (US$ Mn) 4.6. Porter’s Five Force Analysis 4.7. Market Outlook 4.8. Regulatory Scenarios 4.9. Cardiovascular Diseases Prevalence, by Region 4.10. Applied SWOT Analysis 5. Global Market Analysis and Forecasts, By Product Type 5.1. Introduction & Definition 5.2. Key Findings / Developments 5.3. Key Trends 5.4. Market Value Forecast ByProduct Type, 2023–2033 5.4.1. Cardiopulmonary Exercise Testing (CPET) Systems 5.4.2. Stress ECG 5.4.3. Pulse Oximeters 5.4.4. Stress Blood Pressure Monitors 5.4.5. Single-Photon Emission Computed Tomography (SPECT) 5.5. Product Type Comparison Matrix 5.6. Market Attractiveness By Product Type 6. Global Market Analysis and Forecasts, By End-user 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Key Trends 6.4. Market Value Forecast By End-user, 2023–2033 6.4.1. Hospitals 6.4.2. Specialty Clinics/Cardiology Clinics 6.4.3. Ambulatory Surgical Centers 6.4.4. Diagnostic Centers 6.5. Market Attractiveness By End-user 7. Global Market Analysis and Forecasts, By Region 7.1. Key Findings 7.2. Policies and Regulations 7.3. Market Value Forecast By Region 7.3.1. North America 7.3.2. Europe 7.3.3. Asia Pacific 7.3.4. Latin America 7.3.5. Middle East and Africa 7.4. Market Attractiveness By Country/Region 8. North America Market Analysis and Forecast 8.1. Introduction 8.1.1. Key Findings 8.1.2. Key Trends 8.2. Market Value Forecast By Product Type, 2023–2033 8.2.1. Cardiopulmonary Exercise Testing (CPET) Systems 8.2.2. Stress ECG 8.2.3. Pulse Oximeters 8.2.4. Stress Blood Pressure Monitors 8.2.5. Single-Photon Emission Computed Tomography (SPECT) 8.3. Market Value Forecast By End-user, 2023–2033 8.3.1. Hospitals 8.3.2. Specialty Clinics/Cardiology Clinics 8.3.3. Ambulatory Surgical Centers 8.3.4. Diagnostic Centers 8.4. Market Value Forecast By Country, 2023–2033 8.4.1. U.S. 8.4.2. Canada 8.5. Market Attractiveness Analysis 8.5.1. By Product Type 8.5.2. By End-user 8.5.3. By Country 9. Europe Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.1.2. Key Trends 9.2. Market Value Forecast ByProduct Type, 2023–2033 9.2.1. Cardiopulmonary Exercise Testing (CPET) Systems 9.2.2. Stress ECG 9.2.3. Pulse Oximeters 9.2.4. Stress Blood Pressure Monitors 9.2.5. Single-Photon Emission Computed Tomography (SPECT) 9.3. Market Value Forecast By End-user, 2023–2033 9.3.1. Hospitals 9.3.2. Specialty Clinics/Cardiology Clinics 9.3.3. Ambulatory Surgical Centers 9.3.4. Diagnostic Centers 9.4. Market Value Forecast By Country/Sub-region, 2023–2033 9.4.1. U.K. 9.4.2. Germany 9.4.3. France 9.4.4. Italy 9.4.5. Spain 9.4.6. Russia 9.4.7. Rest of Europe 9.5. Market Attractiveness Analysis 9.5.1. By Product Type 9.5.2. By End-user 9.5.3. By Country/Sub-region 10. Asia Pacific Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.1.2. Key Trends 10.2. Market Value Forecast By Product Type, 2023–2033 10.2.1. Cardiopulmonary Exercise Testing (CPET) Systems 10.2.2. Stress ECG 10.2.3. Pulse Oximeters 10.2.4. Stress Blood Pressure Monitors 10.2.5. Single-Photon Emission Computed Tomography (SPECT) 10.3. Market Value Forecast By End-user, 2023–2033 10.3.1. Hospitals 10.3.2. Specialty Clinics/Cardiology Clinics 10.3.3. Ambulatory Surgical Centers 10.3.4. Diagnostic Centers 10.4. Market Value Forecast By Country/Sub-region, 2023–2033 10.4.1. India 10.4.2. China 10.4.3. Japan 10.4.4. Australia & New Zealand 10.4.5. Rest of Asia Pacific 10.5. Market Attractiveness Analysis 10.5.1. By Product Type 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Latin America Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.1.2. Key Trends 11.2. Market Value Forecast By Product Type, 2023–2033 11.2.1. Cardiopulmonary Exercise Testing (CPET) Systems 11.2.2. Stress ECG 11.2.3. Pulse Oximeters 11.2.4. Stress Blood Pressure Monitors 11.2.5. Single-Photon Emission Computed Tomography (SPECT) 11.3. Market Value Forecast By End-user, 2023–2033 11.3.1. Hospitals 11.3.2. Specialty Clinics/Cardiology Clinics 11.3.3. Ambulatory Surgical Centers 11.3.4. Diagnostic Centers 11.4. Market Value Forecast By Country/Sub-region, 2023–2033 11.4.1. Brazil 11.4.2. Mexico 11.4.3. Rest of Latin America 11.5. Market Attractiveness Analysis 11.5.1. By Product Type 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Middle East and Africa Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.1.2. Key Trends 12.2. Market Value Forecast By Product Type, 2023–2033 12.2.1. Cardiopulmonary Exercise Testing (CPET) Systems 12.2.2. Stress ECG 12.2.3. Pulse Oximeters 12.2.4. Stress Blood Pressure Monitors 12.2.5. Single-Photon Emission Computed Tomography (SPECT) 12.3. Market Value Forecast By End-user, 2023–2033 12.3.1. Hospitals 12.3.2. Specialty Clinics/Cardiology Clinics 12.3.3. Ambulatory Surgical Centers 12.3.4. Diagnostic Centers 12.4. Market Value Forecast By Country/Sub-region, 2023–2033 12.4.1. South Africa 12.4.2. GCC Countries 12.4.3. Israel 12.4.4. Rest of Middle East and Africa 12.5. Market Attractiveness Analysis 12.5.1. By Product Type 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Competition Landscape 13.1. Market Player – Competition Matrix (By Tier and Size of companies) 13.2. Market Share Analysis By Company (2022) 13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy) 13.3.1. Koninklijke Philips N.V. 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.1.2. Financial Overview 13.3.1.3. SWOT Analysis 13.3.1.4. Strategic Overview 13.3.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.) 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.2.2. Financial Overview 13.3.2.3. Product Portfolio 13.3.2.4. SWOT Analysis 13.3.2.5. Strategic Overview 13.3.3. General Electric Company (GE Healthcare) 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.3.2. Financial Overview 13.3.3.3. Product Portfolio 13.3.3.4. SWOT Analysis 13.3.3.5. Strategic Overview 13.3.4. MGC Diagnostics Corporation 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.4.2. Financial Overview 13.3.4.3. Product Portfolio 13.3.4.4. SWOT Analysis 13.3.4.5. Strategic Overview 13.3.5. OSI Systems, Inc. (Spacelabs Healthcare) 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.5.2. Financial Overview 13.3.5.3. Product Portfolio. 13.3.5.4. SWOT Analysis 13.3.5.5. Strategic Overview 13.3.6. Masimo 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.6.2. Financial Overview 13.3.6.3. Product Portfolio 13.3.6.4. SWOT Analysis 13.3.6.5. Strategic Overview 13.3.7. NIHON KOHDEN CORPORATION 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.7.2. Financial Overview 13.3.7.3. Product Portfolio 13.3.7.4. SWOT Analysis 13.3.7.5. Strategic Overview 13.3.8. COSMED 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.8.2. Financial Overview 13.3.8.3. Product Portfolio 13.3.8.4. SWOT Analysis 13.3.8.5. Strategic Overview 13.3.9. Halma plc (SunTech Medical, Inc.) 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.9.2. Financial Overview 13.3.9.3. Product Portfolio 13.3.9.4. SWOT Analysis 13.3.9.5. Strategic Overview 13.3.10. Schiller AG 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.10.2. Financial Overview 13.3.10.3. Product Portfolio 13.3.10.4. SWOT Analysis 13.3.10.5. Strategic Overview 13.3.11. Vyaire Medical, Inc. 13.3.11.1. Company Overview (HQ, Business Segments, Employee Strengths) 13.3.11.2. Financial Overview 13.3.11.3. Product Portfolio 13.3.11.4. SWOT Analysis 13.3.11.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Medical Device Classification as per U.S. FDA
Table 02: Code of Federal Regulations, by Type of Device
Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986–1997
Table 04: Medical Device Classification as per European Commission (EC)
Table 05: Global Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 09: North America Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 10: North America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 12: Europe Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 13: Europe Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 17: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 18: Latin America Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 19: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 20: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Product Type, 2023–2033
Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023–2033
Figure 02: Global Market Value Share, by Product (2022)
Figure 03: Global Market Value Share, by Region (2022)
Figure 04: Global Market Value Share, by End-user (2022)
Figure 05: FDA Review Process for 2022
Figure 06: Deaths per Mn Population Caused by Cardiovascular Diseases, by Country, 2012
Figure 07: Global Market Value Share, by Product Type, 2023 and 2033
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiopulmonary Exercise Testing (CPET) Systems, 2023–2033
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress ECG, 2023–2033
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulse Oximeters, 2023–2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress Blood Pressure Monitors, 2023–2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single-Photon Emission Computed Tomography (SPECT), 2023–2033
Figure 13: Global Market Attractiveness, by Product Type, 2023–2033
Figure 14: Global Market Value Share, by End-user, 2023 and 2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2023–2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics/ Cardiology Clinics, 2023–2033
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2023–2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2023–2033
Figure 19: Global Market Attractiveness, by End-user, 2023–2033
Figure 20: Global Market Value Share, by Region, 2023 and 2033
Figure 21: Global Market Attractiveness, by Region, 2023–2033
Figure 22: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 23: North America Market Value Share, by Country, 2023 and 2033
Figure 24: North America Market Attractiveness, by Country, 2023–2033
Figure 25: North America Market Value Share, by Product Type, 2023 and 2033
Figure 26: North America Market Attractiveness, by Product Type, 2023–2033
Figure 27: North America Market Value Share, by End-user, 2023 and 2033
Figure 28: North America Market Attractiveness, by End-user, 2023–2033
Figure 29: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 30: Europe Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 31: Europe Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 32: Europe Market Value Share, by Product Type, 2023 and 2033
Figure 33: Europe Market Attractiveness, by Product Type, 2023–2033
Figure 34: Europe Market Value Share, by End-user, 2023 and 2033
Figure 35: Europe Market Attractiveness, by End-user, 2023–2033
Figure 36: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 37: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 38: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 39: Asia Pacific Market Value Share, by Product Type, 2023 and 2033
Figure 40: Asia Pacific Market Attractiveness, by Product Type, 2023–2033
Figure 41: Asia Pacific Market Value Share, by End-user, 2023 and 2033
Figure 42: Asia Pacific Market Attractiveness, by End-user, 2023–2033
Figure 43: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 44: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 45: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 46: Latin America Market Value Share, by Product Type, 2023 and 2033
Figure 47: Latin America Market Attractiveness, by Product Type, 2023–2033
Figure 48: Latin America Market Value Share, by End-user, 2023 and 2033
Figure 49: Latin America Market Attractiveness, by End-user, 2023–2033
Figure 50: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 51: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 52: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 53: Middle East & Africa Market Value Share, by Product Type, 2023 and 2033
Figure 54: Middle East & Africa Market Attractiveness, by Product Type, 2023–2033
Figure 55: Middle East & Africa Market Value Share, by End-user, 2023 and 2033
Figure 56: Middle East & Africa Market Attractiveness, by End-user, 2023–2033
Figure 57: Global Market Share, by Company, 2022
Figure 58: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Koninklijke Philips N.V.
Figure 59: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Koninklijke Philips N.V.
Figure 60: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Koninklijke Philips N.V.
Figure 61: Breakdown of Net Sales (%), by Region, 2022, Koninklijke Philips N.V.
Figure 62: Breakdown of Net Sales (%), by Business Segment, 2022, Koninklijke Philips N.V.
Figure 63: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 64: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 65: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 66: Breakdown of Net Sales (%), by Region, 2022 (Hill-Rom Holdings, Inc.)
Figure 67: Breakdown of Net Sales (%), by Business Segment, 2022 (Hill-Rom Holdings, Inc.)
Figure 68: Breakdown of Net Sales (%), by Region, 2018 (Welch Allyn)
Figure 69: Breakdown of Net Sales (~ %), by Business Segments, 2022 (Mortara Instrument, Inc.)
Figure 70: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, General Electric Company (GE Healthcare)
Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, General Electric Company (GE Healthcare)
Figure 72: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, General Electric Company (GE Healthcare)
Figure 73: Breakdown of Net Sales (%), by Region, 2022, General Electric Company (GE Healthcare)
Figure 74: Breakdown of Net Sales (%), by Business Segment, 2022, General Electric Company (GE Healthcare)
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, MGC Diagnostics Corporation
Figure 76: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, MGC Diagnostics Corporation
Figure 77: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, MGC Diagnostics Corporation
Figure 78: Breakdown of Net Sales (%), by Region, 2022, MGC Diagnostics Corporation
Figure 79: Breakdown of Net Sales (%), by Business Segment, 2022, MGC Diagnostics Corporation
Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 81: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 82: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 83: Breakdown of Net Sales (%), by Region, 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 84: Breakdown of Net Sales (%), by Business Segment, 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 85: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Masimo
Figure 86: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Masimo
Figure 87: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Masimo
Figure 88: Breakdown of Net Sales (%), by Region, 2022, Masimo
Figure 89: Installed Base (Estimated Units) and Y-o-Y Growth (%), 2018–2022, Masimo
Figure 90: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, NIHON KOHDEN CORPORATION
Figure 91: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, NIHON KOHDEN CORPORATION
Figure 92: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2022, NIHON KOHDEN CORPORATION
Figure 93: Breakdown of Net Sales (%), by Region, 2022, NIHON KOHDEN CORPORATION
Figure 94: Breakdown of Net Sales (%), by Business Segment, 2022, NIHON KOHDEN CORPORATION
Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Halma plc (SunTech Medical, Inc.)
Figure 96: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022, Halma plc (SunTech Medical, Inc.)
Figure 97: Breakdown of Net Sales (%), by Business Segment, 2022, Halma plc (SunTech Medical, Inc.)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request